To guide and standardize the clinical trials of drugs for non-alcoholic steatohepatitis, NMPA has organized the formulation of the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim), which was released on December 20, 2019.